Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lotemax for the initiation of Restasis in dry eye
NCT00407043Phase 4Completed
- Sponsor
- Ophthalmic Consultants of Long Island
- Start
- Nov 2006
- Primary completion
- Sep 2007
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of loteprednol etabonate in dry eye disease (DED), sponsored by Ophthalmic Consultants of Long Island. Started Nov 2006; status: completed.
02
Drugs
loteprednol etabonate
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT00407043.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00407043.